The role of ketamine in major depressive disorders: Effects on parvalbumin-positive interneurons in hippocampus | ||
| dc.conicet.organizacion | Universidad del País Vasco | |
| dc.conicet.organizacion | Universidad del País Vasco | |
| dc.conicet.organizacion | Universidad del País Vasco | |
| dc.conicet.organizacion | Universidad del País Vasco | |
| dc.conicet.organizacion | Universidad del País Vasco | |
| dc.conicet.organizacion | Universidad Nacional de Cuyo | |
| dc.conicet.organizacion | Universidad Nacional de Cuyo | |
| dc.conicet.organizacion | Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Mendoza | |
| dc.conicet.organizacion | Universidad del País Vasco | |
| dc.contributor.author | Barrutieta Arberas, I. | |
| dc.contributor.author | Ortuzar, N. | |
| dc.contributor.author | Vaquero Rodríguez, A. | |
| dc.contributor.author | Picó-Gallardo, M. | |
| dc.contributor.author | Bengoetxea, H. | |
| dc.contributor.author | Guevara, M. A. | |
| dc.contributor.author | Gargiulo, Pascual Angel | |
| dc.contributor.author | Lafuente, J. V. | |
| dc.date.issued | 2023-05 | |
| dc.description.abstract | Major depressive disorder (MDD) is a complex illness that is arising as a growing public health concern. Although several brain areas are related to this type of disorders, at the cellular level, the parvalbumin-positive cells of the hippocampus interplay a very relevant role. They control pyramidal cell bursts, neuronal networks, basic microcircuit functions, and other complex neuronal tasks involved in mood disorders. In resistant depressions, the efficacy of current antidepressant treatments drops dramatically, so the new rapid-acting antidepressants (RAADs) are being postulated as novel treatments. Ketamine at subanesthetic doses and its derivative metabolites have been proposed as RAADs due to their rapid and sustained action by blocking N-methyl-d-aspartate (NMDA) receptors, which in turn lead to the release of brain-derived neurotrophic factor (BDNF). This mechanism produces a rapid plasticity activation mediated by neurotransmitter homeostasis, synapse recovery, and increased dendritic spines and therefore, it is a promising therapeutic approach to improve cognitive symptoms in MDD. | es |
| dc.description.fil | Fil: Barrutieta Arberas, I.. Universidad del País Vasco; España | |
| dc.description.fil | Fil: Ortuzar, N.. Universidad del País Vasco; España | |
| dc.description.fil | Fil: Vaquero Rodríguez, A.. Universidad del País Vasco; España | |
| dc.description.fil | Fil: Picó-Gallardo, M.. Universidad del País Vasco; España | |
| dc.description.fil | Fil: Bengoetxea, H.. Universidad del País Vasco; España | |
| dc.description.fil | Fil: Guevara, M. A.. Universidad Nacional de Cuyo; Argentina | |
| dc.description.fil | Fil: Gargiulo, Pascual Angel. Universidad Nacional de Cuyo; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Mendoza; Argentina | |
| dc.description.fil | Fil: Lafuente, J. V.. Universidad del País Vasco; España | |
| dc.format | application/pdf | es |
| dc.identifier.citation | Barrutieta Arberas, I.; Ortuzar, N.; Vaquero Rodríguez, A.; Picó-Gallardo, M.; Bengoetxea, H.; et al.; The role of ketamine in major depressive disorders: Effects on parvalbumin-positive interneurons in hippocampus; Soc Experimental Biology Medicine; Experimental Biology And Medicine; 248; 7; 5-2023; 588-595 | es |
| dc.identifier.institucional | CONICET | |
| dc.identifier.issn | 1535-3702 | es |
| dc.identifier.repo | CONICET Digital | |
| dc.identifier.uri | http://hdl.handle.net/11336/222316 | |
| dc.journal.number | 7 | es |
| dc.journal.pagination | 588-595 | es |
| dc.journal.pais | Estados Unidos | es |
| dc.journal.title | Experimental Biology And Medicine | es |
| dc.journal.volume | 248 | es |
| dc.language.iso | eng | es |
| dc.publisher | Soc Experimental Biology Medicine | es |
| dc.relation.alternativeid | info:eu-repo/semantics/altIdentifier/url/http://journals.sagepub.com/doi/10.1177/15353702231170007 | |
| dc.relation.alternativeid | info:eu-repo/semantics/altIdentifier/doi/http://dx.doi.org/10.1177/15353702231170007 | |
| dc.rights | info:eu-repo/semantics/openAccess | * |
| dc.rights.uri | https://creativecommons.org/licenses/by-nc-sa/2.5/ar/ | * |
| dc.subject | BRAIN-DERIVED NEUROTROPHIC FACTOR (BDNF) | es |
| dc.subject | HIPPOCAMPUS (HC) | es |
| dc.subject | INTERNEURONS (INS) | es |
| dc.subject | KETAMINE | es |
| dc.subject | MAJOR DEPRESSIVE DISORDER (MDD) | es |
| dc.subject | N-METHYL-D-ASPARTATE RECEPTORS (NMDARS) | es |
| dc.subject.classification | Psiquiatría | es |
| dc.subject.classification | Medicina Clínica | es |
| dc.subject.classification | CIENCIAS MÉDICAS Y DE LA SALUD | es |
| dc.title | The role of ketamine in major depressive disorders: Effects on parvalbumin-positive interneurons in hippocampus | es |
| dc.type | info:eu-repo/semantics/article | |
| dc.type | info:ar-repo/semantics/artículo | |
| dc.type | info:eu-repo/semantics/publishedVersion | |
Archivos
Bloque original
Cargando...
- Nombre:
- CONICET_Digital_Nro.51aaad9b-0947-491e-aebf-428050fbb4ee_S.pdf
- Tamaño:
- 317.9 KB
- Formato:
- Adobe Portable Document Format
- Descripción: